IMR Press / CEOG / Volume 37 / Issue 3 / pii/1630630219321-1279683950

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Editorial
Antisperm antibodies and human reproduction
Show Less
1 The University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Cooper Hospital/University Medical Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, NJ (USA)
Clin. Exp. Obstet. Gynecol. 2010, 37(3), 169–174;
Published: 10 September 2010
Abstract

Purpose: To present strategies in diagnosing and treating infertility related to antisperm antibodies. Methods: Antisperm antibodies (ASA) were detected on sperm using the direct immunobead (IBD) test. Treatments included intrauterine insemination (IUI) with pretreatment with chymotrypsin/galactose vs in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI). Results: Intrauterine insemination with protein digestive enzyme treatment was much more effective than IUI without enzymatic therapy. However IVF with ICSI provided three times the pregnancy rate for males with sperm coated with ASA than IUI with chymotrypsin treated sperm. Conclusions: It is advisable to include measurement for ASA on the initial semen analysis. However, another option is to perform it initially only with an abnormal post-coital test. The decision for IUI with chymotrypsin pretreatment of the sperm vs IVF with ICSI may depend on insurance and financial issues.
Keywords
Antisperm antibodies
Post-coital tests
Intracytoplasmic sperm injection
Protein digestive enzyme
Intrauterine insemination
Share
Back to top